Welcome to LookChem.com Sign In|Join Free

CAS

  • or

50995-48-7

Post Buying Request

50995-48-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

50995-48-7 Usage

Uses

Methyl 2,5-Dibromopentanoate can be used for liquid crystal compounds for display devices.

Check Digit Verification of cas no

The CAS Registry Mumber 50995-48-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,9,9 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 50995-48:
(7*5)+(6*0)+(5*9)+(4*9)+(3*5)+(2*4)+(1*8)=147
147 % 10 = 7
So 50995-48-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H10Br2O2/c1-10-6(9)5(8)3-2-4-7/h5H,2-4H2,1H3

50995-48-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 2,5-Dibromopentanoate

1.2 Other means of identification

Product number -
Other names Methyl 2,5-dibromovalerate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:50995-48-7 SDS

50995-48-7Relevant articles and documents

-

Roff,Brown

, p. 3354 (1973)

-

DIHYDROPYRIMIDO LOOP DERIVATIVE AS HBV INHIBITOR

-

Paragraph 0670; 0671; 0672, (2017/08/01)

Disclosed is a dihydropyrimido fused ring derivative as a HBV inhibitor, and in particular relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof.

IMPROVED PROCESS FOR THE MANUFACTURE OF 1,2-DISUBSTITUTED HEXAHYDROPYRIDAZINE-3-CARBOXYLIC ACIDS AND ESTERS THEREOF

-

Page/Page column 11, (2010/02/11)

The invention relates to an improved process for the manufacture of 1,2-disubstituted hexahydro-pyridazine-3-carboxylic acids and esters thereof by reacting N,N’-disubstituted hydrazine with 2,5-dihalogenated valeric acids and thereof by means of phase transfer catalysis. Said pyridazine carboxylic acids and esters thereof can be used as intermediates for the production of pharmaceutical products

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 50995-48-7